| Trial ID: | L5967 |
| Source ID: | NCT02791035
|
| Associated Drug: |
Oral Administration Of Ipragliflozin
|
| Title: |
Correlation Between Change of HbA1c, Urinary Glucose Excretion and Other Factors in Patients Treated With Ipragliflozin
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Oral administration of Ipragliflozin
|
| Outcome Measures: |
Primary: Correlation between change of HbA1c and urinary glucose excretion, Baseline and week 12 | Secondary: Correlation between reduction in HbA1c and various parameters (HOMA-IR, HOMA-ß, insulinogenic index), Baseline and week 12|Correlation between increase in urinary glucose excretion and various parameters (HOMA-IR, HOMA-ß, insulinogenic index), Baseline and week 12|Change of HbA1c, Baseline and week 12|Chang e of fasting glucose, Baseline and week 12|Change of waist circumference, Baseline and week 12|Percentage of subjects achieving the target HbA1c(<6.5%), week 12
|
| Sponsor/Collaborators: |
Sponsor: Asan Medical Center | Collaborators: Severance Hospital|Samsung Medical Center|Kyung Hee University Hospital at Gangdong|Astellas Pharma Korea, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
|
| Start Date: |
2016-06
|
| Completion Date: |
2017-03
|
| Results First Posted: |
|
| Last Update Posted: |
2017-07-05
|
| Locations: |
Asan Medical Center, Seoul, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02791035
|
